Poster: IBCL-333 Follicular Lymphoma (FL) 3B Patients Have a Superior Risk of an Aggressive Disease at First Event Compared to Those With FL1–3A Treated With Front-Line R-CHOP
Clinical Lymphoma Myeloma and Leukemia(2022)
摘要
ASCO-YIA 3392116949; LRF #818463.
更多查看译文
关键词
IBCL,follicular lymphoma,FL3B,FL1–3A,DLBCL,aggressive relapse
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要